Article · Health news
MHRA recalls one batch of fingolimod
The MHRA issued a Class 2 recall of one batch of Fingolimod Zentiva capsules on 20 August 2026 as a precaution over possible metal particle contamination.
Key points
- The MHRA issued a Class 2 medicines recall on 20 August 2026 for one batch of Fingolimod Zentiva capsules.
- Zentiva Pharma UK Limited issued the recall as a precaution because of a potential risk of contamination with metal particles.
- The particles were found during shelf-life testing, and no reports had been received.
What was announced
The MHRA says Zentiva Pharma UK Limited is recalling one batch of Fingolimod Zentiva capsules, batch number 4L01372H, as a precaution. The reason is a potential risk of contamination with metal particles, which were found during shelf-life testing. The MHRA says no reports have been received to date.
What it means
The notice tells dispensers to stop supplying the affected batch and to quarantine remaining stock for return through their supplier's approved process.
The recall was classed as Class 2 and listed in the MHRA's August 2026 Safety Roundup.
More guides and news
- NICE publishes osteoporosis risk guideline Health news · 29 July 2026
- MHRA: sotorasib and liver monitoring Health news · 25 August 2026
- Lumbar puncture: what happens and what to expect Guide · 3 November 2026
Educational content. This article summarises public guidance and announcements in plain English for education. It is not medical advice and it cannot say what is right for you: speak to a clinician about your own health, call NHS 111 if you are unsure what to do and 999 in an emergency.